← Open Payments lookup

STACEY KRASNOFF: Open Payments

NPI 1700436136 · WEST HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,212 in 86 payments from 27 companies in 2025. Trend: 2023 $685 · 2024 $786 · 2025 $2,212

Food & beverage: $2,212
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$280
Indivior Inc.9$269
Novo Nordisk Inc9$219
Otsuka America Pharmaceutical, Inc.6$149
Takeda Pharmaceuticals U.S.A., Inc.5$148
Lilly USA, LLC6$146
GlaxoSmithKline, LLC.7$145
Lundbeck LLC6$141
ABBVIE INC.4$103
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$60

Products named: SUBLOCADE, REXULTI, TRELEGY ELLIPTA, Wegovy, BREZTRI, FARXIGA, TRINTELLIX, VRAYLAR.

Industry payments across CT — which companies pay providers there.